Overexpression of DCAF13, DNMT3B, KPNA2, EXO1, FANCI, RACGAP1, and ZNF106 in invasive breast carcinoma patients showed poor survival, while overexpression of CDKN2A, SORBS1, and TP63 showed better survival (Figures S4 and S5). This evidence concerns the gene KPNA2 and invasive breast carcinoma.